Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Catapang AB"'
Autor:
Zaiss AK; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Foley EM; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Lawrence R; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Schneider LS; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Hoveida H; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Secrest P; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Catapang AB; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Yamaguchi Y; Sanford-Burnham Medical Research Institute, La Jolla, California, USA., Alemany R; Translational Research Laboratory, IDIBELL-Institut Catala d'Oncologia, Barcelona, Spain., Shayakhmetov DM; Department of Pediatrics and Medicine, Emory University, Atlanta, Georgia, USA., Esko JD; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA., Herschman HR; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA hherschman@mednet.ucla.edu.
Publikováno v:
Journal of virology [J Virol] 2015 Oct 21; Vol. 90 (1), pp. 412-20. Date of Electronic Publication: 2015 Oct 21 (Print Publication: 2016).
Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference.
Autor:
Zaiss AK; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Zuber J; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America., Chu C; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Machado HB; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Jiao J; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Catapang AB; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Ishikawa TO; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Gil JS; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America., Lowe SW; Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America., Herschman HR; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Publikováno v:
PloS one [PLoS One] 2014 Jul 02; Vol. 9 (7), pp. e101263. Date of Electronic Publication: 2014 Jul 02 (Print Publication: 2014).